CLO26-084: Prognostic Value of Sarcopenia in Patients With Metastatic NSCLC Receiving First-Line Immune Checkpoint Inhibitors
Journal of the National Comprehensive Cancer Network · 31.03.2026 · 24 (3.5)
DOI: 10.6004/jnccn.2025.7467 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, erschienen am 31.03.2026. Verfasst von Nikhil Sekar und 26 weiteren Autor:innen. Beteiligte Einrichtung: 1The Ohio State University College of Medicine, Columbus, OH.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- 1The Ohio State University College of Medicine, Columbus, OH.
- 2The Center for Biostatistics, The Ohio State University College of Medicine, Columbus, OH.
- 3Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
- 4National Cheng Kung University Hospital, Tainan, Taiwan.
- 5Division of Hospital Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.
- 6Division of Cancer Prevention and Control, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH.
Zitieren
APA
Sekar, N., Zhao, S., Rudich, A., Johns, N., Hwang, J. D., Su, P. L., Hu, J., Spakowicz, D., Wei, L., Yang, Y., Cheng, T. D., Coss, C., Phelps, M., Parang, B., Gheeya, J., Roof, L., Alahmadi, A., Memmott, R., Kaufman, J., …, & Li, M. (2026). CLO26-084: Prognostic Value of Sarcopenia in Patients With Metastatic NSCLC Receiving First-Line Immune Checkpoint Inhibitors. Journal of the National Comprehensive Cancer Network, 24(3.5). https://doi.org/10.6004/jnccn.2025.7467
Vancouver
Sekar N, Zhao S, Rudich A, Johns N, Hwang JD, Su PL, et al. CLO26-084: Prognostic Value of Sarcopenia in Patients With Metastatic NSCLC Receiving First-Line Immune Checkpoint Inhibitors. Journal of the National Comprehensive Cancer Network. 2026;24(3.5). doi:10.6004/jnccn.2025.7467
BibTeX
@article{Sekar2026,
author = {Sekar, Nikhil and Zhao, Songzhu and Rudich, Alexander and Johns, Natalie and Hwang, Jennifer D and Su, Po-Lan and Hu, Jian and Spakowicz, Daniel and Wei, Lai and Yang, Yuanquan and Cheng, Ting-Yuan David and Coss, Christopher and Phelps, Mitch and Parang, Bobak and Gheeya, Jinesh and Roof, Logan and Alahmadi, Asrar and Memmott, Regan and Kaufman, Jacob and Presley, Carolyn and He, Kai and Burns, Timothy and Shields, Peter and Rolfo, Christian and Carbone, David and Owen, Dwight and Li, Mingjia},
title = {CLO26-084: Prognostic Value of Sarcopenia in Patients With Metastatic NSCLC Receiving First-Line Immune Checkpoint Inhibitors},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2026},
volume = {24},
number = {3.5},
doi = {10.6004/jnccn.2025.7467}
}
EUVIMED